We are live on
!
Find out more
Bessemer Group Portfolio holdings
AUM
$63.6B
1-Year Est. Return
28.76%
This Fund
S&P 500
This Quarter
Est. Return
+9.59%
1 Year Est. Return
+28.76%
3 Year Est. Return
+103.2%
5 Year Est. Return
+139.19%
10 Year Est. Return
+508.5%
AUM
$14B
AUM Growth
+$1.63B
(+13%)
Cap. Flow
+$225M
Cap. Flow
% of AUM
1.61%
Top 10 Holdings %
Top 10 Hldgs %
16.45%
Holding
1,448
New
199
Increased
366
Reduced
275
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$154M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$89.6M |
| 3 |
Lockheed Martin
LMT
|
+$86.9M |
| 4 |
BCM
iPath Pure Beta Broad Commodity ETN
BCM
|
+$76.4M |
| 5 |
iShares MSCI Japan ETF
EWJ
|
+$69.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$98.9M |
| 2 |
GE Aerospace
GE
|
+$95.9M |
| 3 |
Microsoft
MSFT
|
+$92.5M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$67.4M |
| 5 |
Tapestry
TPR
|
+$60.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.01% |
| 2 | Technology | 14.16% |
| 3 | Financials | 12.66% |
| 4 | Industrials | 9.8% |
| 5 | Energy | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Agilent Technologies
A
$39B
| $197K | ﹤0.01% |
4,836
+3,894
| +413% | +$148K |
|
627
Middlesex Water
MSEX
$1.05B
| $197K | ﹤0.01% |
9,427
| – | – |
|
628
AMC Global Media
AMCX
$448M
| $196K | ﹤0.01% |
2,876
+2,765
| +2,491% | +$184K |
|
629
NiSource
NI
$22B
| $196K | ﹤0.01% |
15,183
+763
| +5% | +$9.46K |
|
630
Vanguard Information Technology ETF
VGT
$138B
| $188K | ﹤0.01% |
16,800
| – | – |
|
|
KIOR
631
DELISTED
KIOR, INC CLASS A COM STK
KIOR
| $186K | ﹤0.01% |
110,060
+46,003
| +72% | +$100K |
|
632
VF Corp
VFC
$6.7B
| $185K | ﹤0.01% |
3,156
+2,676
| +558% | +$139K |
|
633
Pentair
PNR
$10.3B
| $184K | ﹤0.01% |
3,527
-47
| -1% | -$2.19K |
|
634
Rockwell Automation
ROK
$51.6B
| $182K | ﹤0.01% |
1,532
+1,305
| +575% | +$145K |
|
|
GXP
635
DELISTED
Great Plains Energy Incorporated
GXP
| $182K | ﹤0.01% |
+7,530
| New | +$178K |
|
|
APC
636
DELISTED
Anadarko Petroleum
APC
| $179K | ﹤0.01% |
2,268
-178,725
| -99% | -$16M |
|
637
AGCO
AGCO
$8.68B
| $178K | ﹤0.01% |
+3,000
| New | +$179K |
|
638
Vodafone
VOD
$36.5B
| $178K | ﹤0.01% |
4,429
-421
| -9% | -$15.8K |
|
639
iShares MSCI Singapore ETF
EWS
$1.03B
| $174K | ﹤0.01% |
6,623
-250
| -4% | -$6.72K |
|
|
SI
640
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $172K | ﹤0.01% |
1,238
| – | – |
|
|
WFT
641
DELISTED
Weatherford International plc
WFT
| $170K | ﹤0.01% |
10,956
-71,657
| -87% | -$1.14M |
|
642
Annaly Capital Management
NLY
$17B
| $168K | ﹤0.01% |
4,200
+1,375
| +49% | +$59.7K |
|
643
Allstate
ALL
$67.2B
| $164K | ﹤0.01% |
3,024
-400
| -12% | -$21.3K |
|
644
iShares US Pharmaceuticals ETF
IHE
$1.49B
| $163K | ﹤0.01% |
4,140
| – | – |
|
645
Vanguard Small-Cap Growth ETF
VBK
$23.4B
| $160K | ﹤0.01% |
+1,310
| New | +$155K |
|
646
Energy Transfer Partners
ET
$68.5B
| $159K | ﹤0.01% |
7,800
+3,400
| +77% | +$61.2K |
|
|
APU
647
DELISTED
AmeriGas Partners, L.P.
APU
| $158K | ﹤0.01% |
3,530
| – | – |
|
|
NS
648
DELISTED
NuStar Energy L.P.
NS
| $156K | ﹤0.01% |
3,063
| – | – |
|
649
State Street SPDR S&P Dividend ETF
SDY
$22B
| $153K | ﹤0.01% |
2,114
+1,863
| +742% | +$134K |
|
650
Clean Energy Fuels
CLNE
$436M
| $147K | ﹤0.01% |
11,425
| – | – |
|
Similar funds
Bessemer Group's Q4 2013 Portfolio in Review
As of Q4 2013, Bessemer Group held 1,448 positions worth $14B, up 13% from $12.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Bessemer Group's Q4 2013 filing shows 199 new, 366 increased, 275 reduced and 98 closed positions. Its largest new stake was iPath Pure Beta Broad Commodity ETN: 1,927,069 shares worth $76.1M. The largest sale was Teva Pharmaceuticals, an estimated $98.9M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- Bessemer Group's largest Q4 2013 buy was iPath Pure Beta Broad Commodity ETN: 1,927,069 shares worth $76.1M.
- Bessemer Group added most to Viatris in Q4 2013, an estimated $154M increase.
- Bessemer Group's biggest Q4 2013 reduction was Teva Pharmaceuticals, cutting an estimated $98.9M.
- Bessemer Group fully exited Rayonier in Q4 2013, selling an estimated $33.4M.
- Bessemer Group's ten largest holdings make up 16% of its $14B portfolio in Q4 2013.
- Bessemer Group opened 199 new positions and closed 98 in Q4 2013.
- Bessemer Group's portfolio value rose 13% quarter-over-quarter to $14B.
Based on Bessemer Group's 13F filing for Q4 2013, filed 18 Feb 2014.